Agenda
3rd ExciPerience 2023 – 13 & 14 September 2023
Moderation
Claire Thompson, CEO of Agility Life Sciences
Prof. Simon Gaisford, PhD, Professor of Pharmaceutics at the University College London
Philippe Tschopp, Founder of PharmaExcipients
Agenda 2023
Timezone: Central European Time
| 1. Day | Sep 13 - Session 1 | Sep 13 - Session 2 | 2. Day | Sep 14 - Session 1 | Sept 14 - Session 2 |
|---|---|---|---|---|---|
| 12:00 - 12:45 CET | A.I. enhanced networking carousel | 12:00 - 12:30 CET | A.I. enhanced networking carousel | ||
| 12:45 - 13:00 | Welcome message and overview Philippe Tschopp | 12:30 - 12:45 | Introduction Day 2 Philippe Tschopp |
||
| 12:45 - 13.00 Session 1 12:45 - 13.00 Session 2 | A new and sustainable microcrystalline cellulose Kalle Riihinen, Nordic Bioproducts Group | Tableting of fluidized bed granules containing living microorganisms Karl Vorländer |
|||
| 13:00- 14:00 | Keynote Sustainability – fact or fiction? How to bring sustainability into daily business operations of pharmaceutical companies Prof. Dr. Stephan Haubold | 13:00 - 14:00 Session 1 12:45 - 13:45 Session 2 | Microneedles: Tiny structures with big potential Prof. Ryan F. Donnelly | continued: Tableting of fluidized bed granules containing living microorganisms | |
| 14:00 - 15:00 | Pharmacy in a digital age Dr. Atheer Awad | Fluid bed processing of micropellets to overcome swallowing issues – not a dream any more Prof. Fang Liu and Dr. Norbert Pöllinger | 14:00 - 15:00 Session 1 13:45 - 14:45 Session 2 | Machine learning approaches to the prediction of powder flow behaviour of pharmaceutical materials from physical properties Laura Pereira Díaz | A Journey into the Wonderful World of Emerging Pharmaceutical & Biopharmaceutical Technologies Prof. Dimitrios A. Lamprou |
| 15:00 - 15:30 | A.I. enhanced networking carousel | Excipient information at exhibitor booths and discussion tables | 15:00 - 15:30 | A.I. enhanced networking carousel | Excipient information at exhibitor booths and discussion tables |
| 15:30 - 16:30 | The contribution of excipients towards patient centric drug product design Dr. Nélio Drumond | 15:30 - 16;00 Chiral Analytics for Drug Development and Quality Assurance Carin Lightner, Enantios Poly(jasmine lactone): A versatile drug delivery platform Dr. Kuldeep Bansal, JasminePro 16:00 - 16:30 How plant-based excipients can be used for gelatin-free soft capsules Steve Amoussou-Guenou, Roquette Pharma Solutions | 15:30 - 16:30 | Selecting Excipients for Improved Drug Palatability David Tisi | Radically simplifying individualized treatments Jonas Bäck, Ondosis Templated inverted particles (TIP) as a novel pharmaceutical excipient Prof. Dr. Jörg Huwyler, Galvita TaBlitz: Globally Revolutionizing Tablet Design Casey Davis, Tablitz |
| 16:30 - 17:30 | Oral Delivery of Biologics using Microneedle Capsules Alex Abramson | Moisture Protection Coatings – Strategies, Materials and Analysis Marek Lachmann, Biogrund | 16:30 - 17:30 | Formulation and Delivery of RNA Vaccines: The Carrier is Key Prof. Camilla Foged | Risk approach Excipients Janeen Skutnik-Wilkinson |
| 17:30 onwards | Lounge area networking | 17:30 onwards | Lounge area networking | ||
Registration
Agenda 2022
Timezone: Central European Time
| 1. Day | March 09 - Session 1 | March 09 - Session 2 | 2. Day | March 10 - Session 1 | March 10 - Session 2 |
|---|---|---|---|---|---|
| 12:00 - 13:00 CET | A.I. enhanced networking carousel | 12:00 - 12:15 CET | Introduction Philippe Tschopp |
||
| 13:00 - 13:15 | Welcome message and overview Philippe Tschopp | 12:15 - 13:00 | The role of 3D printing in treatments for rare diseases Prof. Simon Gaisford | Early Phase Pharmaceutical Product Development using Quality by Design tools Prof. Walkiria Schlindwein |
|
| 13:15 - 14:00 | Opportunity and challenge of artificial intelligence (AI) in drug delivery Prof. Defang Ouyang | Biopharmaceutical Implications of Excipient Variability on Drug Solubility and Dissolution Dr Nikoletta Fotaki | 13:00 - 14:00 | Sex matters: Excipients actively modulate drug response differently in males and females Christine Madla, PhD | Formulation trends, including Continuous Manufacturing tableting Dr Maj-Britt Cepok The Developability Classification System for Poorly Soluble Drug Formulation Strategies Dr Gudrun Birk |
| 14:00 - 15:00 | In-silico polymer screenings for rational amorphous solid dispersion development Dr Christian Lübbert Polymers and API crystallization: from controlling form and habit to ASD Dr Dan Dumitrescu | Pulmonary Delivery of siRNA as Antiviral Treatment of SARS-CoV-2 Infections Prof. Olivia Merkel | 14:00 - 15:00 | A.I. enhanced networking carousel | Excipient innovation presentations in lobby and exhibitor booths |
| 15:00 - 16:00 | A.I. enhanced networking carousel | Excipient innovation presentations in lobby and exhibitor booths | 15:00 - 16:00 | Start-Up speeches: Microneedle Device: Promise Effective Oral Delivery of Biologics Dr Anat Raz Amorphous Formulation of Poorly Soluble Drugs in Mesoporous Magnesium Carbonate Dr Jonas Fagerberg | DC-lactoses: cornerstones for reliable continuous manufacturing processes Dr Sonja Bauhuber Key advantages using sugar spheres in multiparticulate oral drug delivery Dr Philipp Werner Enabling Novel Pharmaceutical Therapies through 3D-printing Kyle Smith |
| 16:00 - 17:00 | Numerical methods in the design of solid pharmaceutical formulations: state of the art, and future challenges Dr Maxim Puchkov | Formulations for infants and young children: Innovative use of excipients in film coating Dr Fang Liu | 16:00 - 17:00 | Application of lipids in challenging processes: Spray-drying and 3D printing Dr Sharareh Salar-Behzadi | The complexities of Excipient Registration in China and potential solutions Dave Schoneker |
| 17:00 - 18:00 | Tumor neurons and patient sex affect nanomedicine efficacy Prof. Avi Schroeder | Phospholipids as bioactive excipients in the treatment of liver fibrosis Prof. Paola Luciani | 17:00 - 18:00 | Speeches on titanium dioxide (TiO2): TiO2 free film coating formulations - technical aspects Dr Mahmud Yunis The EFSA Opinion of E171: A TDMA Perspective Dr David Lockley Potential Global Regulatory Impact of the EU E171 Ban on Dietary Supplements and Pharmaceuticals Dave Schoneker |
|
| 18:00 - 19:00 | Keynote: How 3D printing is changing medicine Prof. Joseph DeSimone | 18:00 - 19:00 | Experts panel on titanium dioxide (TiO2) | ||
| 19:00 - 20:00 | Lounge area networking | 19:00 - 20:00 | Lounge area networking | ||